These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24294746)

  • 1. [Effect of Lactobacillus casei var rhamnosus (Gynophilus) in restoring the vaginal flora by female patients with bacterial vaginosis--randomized, open clinical trial].
    Kovachev S; Dobrevski-Vacheva R
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():48-53. PubMed ID: 24294746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Probiotic monotherapy of bacterial vaginosis: a open, randomized trial].
    Kovachev S; Dobrevski-Vacheva R
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():36-42. PubMed ID: 24294744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of combined 5-nitroimidazole and probiotic therapy of bacterial vaginosis: randomized open trial].
    Kovachev S; Vatcheva-Dobrevski R
    Akush Ginekol (Sofiia); 2013; 52(3):19-26. PubMed ID: 24283058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis.
    Recine N; Palma E; Domenici L; Giorgini M; Imperiale L; Sassu C; Musella A; Marchetti C; Muzii L; Benedetti Panici P
    Arch Gynecol Obstet; 2016 Jan; 293(1):101-107. PubMed ID: 26142892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [GynOphilus--a winning relay].
    Kovachev S
    Akush Ginekol (Sofiia); 2012; 51 Suppl 1():41-4. PubMed ID: 23236678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial.
    Anukam K; Osazuwa E; Ahonkhai I; Ngwu M; Osemene G; Bruce AW; Reid G
    Microbes Infect; 2006 May; 8(6):1450-4. PubMed ID: 16697231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term vaginal administration of Lactobacillus rhamnosus as a complementary approach to management of bacterial vaginosis.
    Marcone V; Rocca G; Lichtner M; Calzolari E
    Int J Gynaecol Obstet; 2010 Sep; 110(3):223-6. PubMed ID: 20573348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Lactobacillus rhamnosus BMX 54 application to restore a balanced vaginal ecosystem: a promising solution against HPV-infection.
    Palma E; Recine N; Domenici L; Giorgini M; Pierangeli A; Panici PB
    BMC Infect Dis; 2018 Jan; 18(1):13. PubMed ID: 29304768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV.
    Hummelen R; Changalucha J; Butamanya NL; Cook A; Habbema JD; Reid G
    Int J Gynaecol Obstet; 2010 Dec; 111(3):245-8. PubMed ID: 20801446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.
    Marcotte H; Larsson PG; Andersen KK; Zuo F; Mikkelsen LS; Brandsborg E; Gray G; Laher F; Otwombe K
    BMC Infect Dis; 2019 Sep; 19(1):824. PubMed ID: 31533663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Lactobacillus casei rhamnosus Lcr35 in restoring the normal vaginal flora after antibiotic treatment of bacterial vaginosis.
    Petricevic L; Witt A
    BJOG; 2008 Oct; 115(11):1369-74. PubMed ID: 18823487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study.
    Vicariotto F; Mogna L; Del Piano M
    J Clin Gastroenterol; 2014; 48 Suppl 1():S106-12. PubMed ID: 25291116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lacticaseibacillus rhamnosus TOM 22.8 (DSM 33500) is an effective strategy for managing vaginal dysbiosis, rising the lactobacilli population.
    Vaccalluzzo A; Pino A; Grimaldi RL; Caggia C; Cianci S; Randazzo CL
    J Appl Microbiol; 2024 May; 135(5):. PubMed ID: 38755019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent Lactobacilli-containing Vaginal Probiotic or Metronidazole Use to Prevent Bacterial Vaginosis Recurrence: A Pilot Study Incorporating Microscopy and Sequencing.
    van de Wijgert JHHM; Verwijs MC; Agaba SK; Bronowski C; Mwambarangwe L; Uwineza M; Lievens E; Nivoliez A; Ravel J; Darby AC
    Sci Rep; 2020 Mar; 10(1):3884. PubMed ID: 32127550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis.
    Anukam KC; Osazuwa E; Osemene GI; Ehigiagbe F; Bruce AW; Reid G
    Microbes Infect; 2006 Oct; 8(12-13):2772-6. PubMed ID: 17045832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal impact of the oral administration of total freeze-dried culture of LCR 35 in healthy women.
    Bohbot JM; Cardot JM
    Infect Dis Obstet Gynecol; 2012; 2012():503648. PubMed ID: 22701297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of vaginal administration of Lactobacillus rhamnosus following conventional metronidazole therapy: how to lower the rate of bacterial vaginosis recurrences.
    Marcone V; Calzolari E; Bertini M
    New Microbiol; 2008 Jul; 31(3):429-33. PubMed ID: 18843900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora.
    Reid G; Beuerman D; Heinemann C; Bruce AW
    FEMS Immunol Med Microbiol; 2001 Dec; 32(1):37-41. PubMed ID: 11750220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failure.
    Verwijs MC; Agaba SK; Darby AC; van de Wijgert JHHM
    Am J Obstet Gynecol; 2020 Feb; 222(2):157.e1-157.e13. PubMed ID: 31404542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Oral Probiotic
    Yang S; Reid G; Challis JRG; Gloor GB; Asztalos E; Money D; Seney S; Bocking AD
    Nutrients; 2020 Jan; 12(2):. PubMed ID: 32019222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.